BIOMAT Database Logo BIOMAT Database Logo

[The duration of hemosorption in patients with chronic renal failure]. 1988

V A Maksimenko, and O S Belorusov, and E V Gorbovitskiĭ, and Iu E Mikhaĭlov, and I M Lanskaia

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002606 Charcoal An amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. (Grant & Hackh's Chemical Dictionary, 5th ed) Activated Charcoal,Actidose,Actidose-Aqua,Adsorba,Carbomix,Charbon,CharcoAid,CharcoCaps,Charcodote,Formocarbine,Insta-Char,Kohle-Compretten,Kohle-Hevert,Kohle-Pulvis,Kohle-Tabletten Boxo-Pharm,Liqui-Char,Norit,Ultracarbon,Charcoal, Activated
D006464 Hemoperfusion Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose). Hemosorption,Hemoperfusions,Hemosorptions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013727 Terminal Care Medical and nursing care of patients in the terminal stage of an illness. End-Of-Life Care,End of Life Care,Care, End-Of-Life,Care, Terminal,End-Of-Life Cares
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

V A Maksimenko, and O S Belorusov, and E V Gorbovitskiĭ, and Iu E Mikhaĭlov, and I M Lanskaia
[Hemosorption as a method of treating patients with chronic renal failure].
October 1977, Sovetskaia meditsina,
V A Maksimenko, and O S Belorusov, and E V Gorbovitskiĭ, and Iu E Mikhaĭlov, and I M Lanskaia
[Electromyography in patients in the terminal stages of chronic renal failure treated with regular hemodialysis and hemosorption].
January 1984, Urologiia i nefrologiia,
V A Maksimenko, and O S Belorusov, and E V Gorbovitskiĭ, and Iu E Mikhaĭlov, and I M Lanskaia
[Use of hemosorption and hemodialysis in the treatment of chronic renal failure].
January 1981, Terapevticheskii arkhiv,
V A Maksimenko, and O S Belorusov, and E V Gorbovitskiĭ, and Iu E Mikhaĭlov, and I M Lanskaia
[Hemosorption in patients with hepatic failure].
January 1984, Sovetskaia meditsina,
V A Maksimenko, and O S Belorusov, and E V Gorbovitskiĭ, and Iu E Mikhaĭlov, and I M Lanskaia
[Hemosorption in the complex treatment of patients with acute and chronic kidney failure].
January 1983, Sovetskaia meditsina,
V A Maksimenko, and O S Belorusov, and E V Gorbovitskiĭ, and Iu E Mikhaĭlov, and I M Lanskaia
[Use of hemosorption in chronic kidney failure].
June 1984, Klinicheskaia meditsina,
V A Maksimenko, and O S Belorusov, and E V Gorbovitskiĭ, and Iu E Mikhaĭlov, and I M Lanskaia
[Effect of hemosorption on blood insulin levels in patients with chronic liver failure].
August 1983, Vrachebnoe delo,
V A Maksimenko, and O S Belorusov, and E V Gorbovitskiĭ, and Iu E Mikhaĭlov, and I M Lanskaia
[Effect of hemodialysis and hemosorption on blood serum level of medium-molecular components in patients with chronic renal failure].
January 1984, Terapevticheskii arkhiv,
V A Maksimenko, and O S Belorusov, and E V Gorbovitskiĭ, and Iu E Mikhaĭlov, and I M Lanskaia
[Pharmacokinetics of ampicillin in patients with chronic renal insufficiency during hemodialysis and hemosorption].
May 1985, Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology,
V A Maksimenko, and O S Belorusov, and E V Gorbovitskiĭ, and Iu E Mikhaĭlov, and I M Lanskaia
[Possibilities of hemosorption for increasing the effectiveness of treatment of patients with renal tuberculosis with chronic renal insufficiency].
January 1985, Problemy tuberkuleza,
Copied contents to your clipboard!